New data show the market for companies that provide drug screen services—which would include urgent care operators who offer occupational medicine services—should grow at a 10.2% clip annually through 2022. By that time, the total market value would be $8.63 billion (up from $5.32 billion in 2017). The Drug Screening Market Report from ReportsnReports reasons that demand will continue to be driven by growing drug and alcohol consumption among workers, combined with increased enforcement of applicable laws, policies, and employer health initiatives. The report also indicates the drug screening market will continue to become more competitive, perhaps incentivizing providers to shore up existing business or get more aggressive in seeking new business sooner than later. North America is expected to account for the largest share of the drug screening market, followed by Europe. Urine samples are expected to dominate, compared with breath, hair, oral, and other samples, because they tend to be accurate in detecting multiple substances, are relatively cost effective, and offer instant results.
Drug Screening Market Expected to See Healthy Growth Through 2022